Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL) [Phase 1, Phase 2]
Clinical trial update for BrEPEM-LH-22017 in older patients with untreated Hodgkin lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer [Phase 2]
Phase 2 trial evaluating romiplostim to treat low platelets after chemotherapy and autologous hematopoietic cell transplantation in people w…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial of PD-1 antibody SHR-1210 in adults with relapsed or refractory classic Hodgkin's lymphoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant [Phase 1]
Phase 1 trial evaluating the CMV-MVA Triplex vaccine given to stem cell donors to prevent cytomegalovirus viremia in recipients of allogenei…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy [Phase 2]
Phase 2 clinical trial update for MGTA-456 in high-risk hematologic malignancies; results were posted in 2024 and the study is currently act…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy with or without radiation in low and intermediate risk Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: BV-AVD-R Treatment Children Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update for BV-AVD-R in pediatric Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of brentuximab vedotin in classical Hodgkin lymphoma was terminated, with results posted in December 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating prologolimab as monotherapy or with bendamustine for relapsed/refractory classical Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma [Phase 4]
A Phase 4 clinical trial comparing surgery alone versus surgery with additional systemic therapy regimens for stage IA/IIA nodular lymphocyt…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study [Phase 2]
Phase 2 clinical trial update evaluating avelumab as frontline treatment for advanced classical Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating PET scans to plan treatment in patients undergoing combination chemotherapy for stage IA or stage IIA Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
A completed clinical trial evaluating cardiac magnetic resonance imaging in patients with non-Hodgkin lymphoma or Hodgkin lymphoma receiving…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Brentuximab for Newly Diagnosed Hodgkin Disease [Phase 2]
Phase 2 clinical trial update evaluating brentuximab for newly diagnosed Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating retreatment with brentuximab vedotin in classic Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma h…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy followed by donor stem cell transplant in relapsed or high-risk primary refractory Hodgkin…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Methods of T Cell Depletion Trial (MoTD) [Phase 2]
Phase 2 trial update for methods of T cell depletion in various hematologic malignancies is ongoing.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP) [Phase 2]
A Phase 2 trial assessing the combination of nivolumab with DHAP in relapsed or refractory classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma [Phase 2]
Phase II study investigating frontline pembrolizumab in Hodgkin lymphoma is in progress with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant [Phase 1, Phase 2]
This update reports results from a Phase 1/2 clinical trial of a gene therapy for HIV-related lymphomas in patients undergoing stem cell tra…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation [Phase 2]
Phase 2 trial update on once-daily targeted IV busulfan as part of reduced-toxicity conditioning for patients with refractory lymphomas unde…
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating a vaccine therapy to reduce cytomegalovirus events in patients with hematologic malignancies undergoing donor stem …
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluates the combination of ibrutinib and brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. The study has com…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]
Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic mali…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS [Phase 2]
Phase II trial evaluating nivolumab with low-dose radiotherapy for incomplete responders with Hodgkin lymphoma is terminated; results posted…